COO — Cooper Companies Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Cooper Companies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2019 October 31st	2020 October 31st	2021 October 31st	2022 October 31st	2023 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,653	2,431	2,923	3,308	3,593
Cost of Revenue
Gross Profit	1,757	1,535	1,956	2,166	2,358
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,107	2,119	2,417	2,801	3,060
Operating Profit	547	312	506	508	533
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	477	267	492	475	413
Provision for Income Taxes
Net Income After Taxes	461	238	2,945	386	294
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	467	238	2,945	386	294
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	467	238	2,945	386	294
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.586	1.32	14.8	2.08	1.64
Dividends per Share